EP2238250

USE OF ANTI-CONNEXIN 43 POLYNUCLEOTIDES, PEPTIDES OR ANTIBODIES FOR THE TREATMENT OF ORTHOPEDIC CONDITIONS

  • :
    EP einkaleyfi: Þýðing ekki lögð inn
  • :
    22.12.2008
  • :
    19.7.2017
  • :
    08866608.6
  • :
    21.12.2028
  • :
    21.12.2018
  • :
    USE OF ANTI-CONNEXIN 43 POLYNUCLEOTIDES, PEPTIDES OR ANTIBODIES FOR THE TREATMENT OF ORTHOPEDIC CONDITIONS

22.12.2008
19.7.2017
21.12.2018
  • :
    Ocunexus Therapeutics, Inc.
  • :
    12481 High Bluff Drive, Suite 150, 92130, San Diego CA, US
  • :
    BECKER, David, L.
  • :
    Abbots LangleyHertfordshire, GB
  • :
    GREEN, Colin, R.
  • :
    Auckland, NZ
  • :
    DUFT, Bradford, J.
  • :
    Rancho Santa FeCA, US
  • :
    8660 P
  • :
    21.12.2007
  • :
    US
  • :
    US2008014020
  • :
    22.12.2008
  • :
    C12N 15/113, A61K 38/17, A61P 41/00, A61P 19/02

: 10

: 9.11.2017

: 21.12.2018

: Árnason Faktor